Role of metabolism in arsenic toxicity

Pharmacology and Toxicology

Volumn 89, Issue 1, 2001, Pages 1-5

  Vahter, Marie ^a   Concha, Gabriela ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; CACODYLIC ACID; DRINKING WATER; METHANEARSONIC ACID; METHYL GROUP; S ADENOSYLMETHIONINE; THIOL DERIVATIVE;

BIOTRANSFORMATION; CHEMICAL BINDING; DETOXIFICATION; EXPOSURE; HEAVY METAL POISONING; KIDNEY; METABOLISM; METABOLITE; METHYLATION; PRIORITY JOURNAL; SHORT SURVEY; TISSUE DISTRIBUTION; URINARY EXCRETION;

MAMMALIA;

EID: 0034917334     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2001.d01-128.x     Document Type: Short Survey

References (67)

1. Anundi I., J. Högberg & M. Vahter: GSH release in bile as influenced by arsenite. FEBS Lett. 1982, 45, 285-288.
2. Aposhian, H. V: Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Ann. Rev. Pharmacol. Toxicol. 1997, 37, 397-419.
3. Aposhian, H. V, E. S. Gurzau, X. C. Le, A. Gurzau, S. M. Healy, X. Lu, M. Ma, L. Yip, R. A. Zakharyan, R. M. Maiorino, R. C. Dart, M. G. Tircus, D. Gonzalez-Ramirez, D. L. Morgan, D. Avram & M. M. Aposhian: Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem. Res. Toxicol. 2000, 13, 693-697.
4. Bogdan, G. M., A. Sampayo-Reyes & H. V. Aposhian: Arsenic binding proteins of mammalian systems: I. Isolation of three arsenite-binding proteins of rabbit liver. Toxicol. 1994, 93, 175-193.
5. Buchet, J. P., R. Lauwerys & H. Roels: Comparison of the urinary excretion of arsenic metabolites after a single dose of sodium arsenite, monomethylarsonate or dimethylarsinate in man. Int. Arch. Occup. Environ. Health. 1981, 48, 71-79.
6. Buchet, J. P. & R. Lauwerys: Study of factors influencing in vivo methylation of inorganic arsenic in rats. Toxicol. Appl. Pharmacol. 1987, 91, 65-74.
7. Buchet, J. P. & R. Lauwerys: Role of thiols in the in vitro methylation of inorganic arsenic by rat liver cytosol. Biochem. Pharmacol. 1988, 37, 3149-3153.
8. Chiou H.-Y., Y. M. Hsueh, L.-L. Hsieh, L.-I. Hsu, Y.-H. Hsu, F.-I. Hsieh, M.-L. Wei, H.-C. Chen, H.-T. Yang, L. C. Leu, T.-H Chu, C. Chen-Wu, M.-H. Yang & C.-J. Chen: Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mut. Res. 1997, 386, 197-207.
9. Concha, G., G. Vogler, B. Nermell & M. Vahter: Metabolism of inorganic arsenic in children with chronic high arsenic exposure in northern Argentina. Environ. Health Perspect. 1998, 106, 355-359.
10. Cullen, W. R., B. C. McBride & J. Reglinski: The reaction of methyl arsenicals with thiols: some biological implications. J. Inorg. Biochem. 1984, 21, 179-193.
11. Das, D., A. Chatterjee, B. K. Mandai, G. Samanta, D. Chakraborti & B. Chanda: Arsenic in ground water in six districts of West Bengal, India: The biggest arsenic calamity in the world. Part 2. Arsenic concentration in drinking water, hair, nails, urine, skin scale and liver tissue (biopsy) of the affected people. Analyst 1995, 120, 917-924.
12. Delnomdedieu, M., M. M. Basti, J. D. Otvos & D. J. Thomas: Reduction and binding of arsenate and dimethylarsinate by glutathione: a magnetic resonance study. Chem.-Biol. Interact. 1994a, 90, 139-155.
13. Delnomdedieu, M., M. M. Basti, M. Styblo, J. D. Otvos & D. J. Thomas: Complexation of arsenic species in rabbit erythrocytes. Chem. Res. Toxicol. 1994b, 7, 681-387.
14. Del Razo, L. M., G. G. García-Vargas, H. Vargas, A. Albores, M. E. Gonsebatt, R. Montero, P. Ostrosky-Wegman, M. Kelsh & M. E. Cebrián: Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. Arch. Toxicol. 1997, 71, 211-217.
15. Del Razo, L. M., M. Styblo & D. J. Thomas: Determination of trivalent methylated arsenic species in water, cultured rat hepatocytes and human urine. Fourth International Conference on Arsenic Exposure and Health Effects. Poster presentation. San Diego, CA, June 18-22, 2000.
16. Dulout, F. N., C. A. Grillo, A. I. Seoane, C. R. Maderna, R. Nilsson, M. Vahter, F. Darroudi & A. T. Natarajan: Chromosomal aberrations in peripheral blood lymphocytes from native Andean women and children from Northwestern Argentina exposed to arsenic in drinking water. Mutat. Res. 1996, 370, 151-158.
17. Fòa, V, A. Colombi, M. Maroni, M. Buratti & G. Calzaferri: The speciation of the chemical forms of arsenic in the biological monitoring of exposure to inorganic arsenic. Sci. Total Environ. 1984, 34, 241-259.
18. Geubel, A. P., M. C. Mairlot, J. P. Buchet & R. Lauwerys: Abnormal methylation capacity in human liver cirrhosis. Int. J. Clin. Pharmacol. Res. 1988, 8, 117-122.
19. Gregus, Z., A. Gyurasics & I. Csanaky: Biliary and urinary excretion of inorganic arsenic: Monomethylarsonous acid as a major biliary metabolite in rats. Toxicol. Sci. 2000, 56, 18-25.
20. Gyurasics, Á., F. Varga & Z. Gregus: Glutathione-dependent biliary excretion of arsenic. Biochem. Pharmacol. 1991, 42, 465-468.
21. Healy, S. M., E. A. Casarez, F. Ayala-Fierro & H. V. Aposhian: Enzymatic methylation of arsenic compounds V. arsenite methyltransferase activity in tissues of mice. Toxicol. Appl. Pharmacol. 1998, 148, 65-70.
22. Hirata, M., A. Hisanaga, A. Tanaka & N. Ishinishi: Glutathione and methylation of inorganic arsenic in hamsters. Appl. Organomet. Chem. 1988, 2, 315-321.
23. Hirata, M., A. Tanaka, A. Hisanaga & N. Ishinishi: Effects of glutathione depletion on the acute nephrotoxic potential of arsenite and on the arsenic metabolism in the hamster. Toxicol. Appl. Pharmacol. 1990, 106, 469-481.
24. Hopenhayn-Rich, C., A. H. Smith & H. M. Goeden: Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ. Res. 1993, 60, 161-177.
25. Hughes, M. F., M. Menache & D. J. Thomas: Dose-dependent disposition of sodium arsenite in mice following acute oral exposure. Fund. Appl. Toxicol. 1994, 22, 80-89.
26. Hughes, M. F. & E. M. Kenyon: Dose-dependent effects on the disposition of monomethylarsonic acid and dimethylarsinic acid in the mouse after intravenous administration. J. Toxicol. Environ. Health 1998, 53, 95-112.
27. Le, X. C., M. Ma, W. R. Cullen, H. V. Aposhian, X. Lu & B. Zheng: Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ. Health Perspect. 2000, 108, 1015-1018.
28. Lin, S., W. R. Cullen & D. J. Thomas: Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem. Res. Toxicol. 1999, 12, 924-930.
29. Lowell, M. A. & J. G. Farmer: Arsenic speciation in urine from humans intoxicated by inorganic arsenic compounds. Human Toxicol. 1985, 4, 203-214.
30. 3. Its significance for the duration of BAL therapy. Clin. Toxicol. 1981, 18, 1067-1075.
31. 74As) arsenite in mice and rabbits. Chem.-Biol. Interact. 1984, 50, 49-57.
32. Marafante, E., M. Vahter & J. Envall: The role of the methylation in the detoxication of arsenate in the rabbit. Chem.-Biol. Interact. 1985, 56, 225-238.
33. Marafante, E., M. Vahter, H. Norin, J. Envall, M. Sandström, A. Christakopoulos & R. Ryhage: Biotransformation of dimethylarsinic acid in mouse, hamster and man. J. Appl. Toxicol. 1987, 7, 111-117.
34. Moore, M. M., K. Harrington-Brock & C. L. Doerr: Relative genotoxic potency of arsenic and its methylated metabolites. Mutat. Res. 1997, 386, 279-290.
35. National Research Council: Arsenic in drinking water. National Academy of Sciences, Washington, D.C., USA, 1999.
36. III) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 2000, 163, 203-207.
37. Radabaugh, T. R. & H. V. Aposhian: Enzymatic reduction of arsenic compounds in mammalian systems: Reduction of arsenate to arsenite by human liver arsenate reductase. Chem. Res. Toxicol. 2000, 13, 26-30.
38. Sakurai, T., T. Kaise & C. Matsubara: Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms. Chem. Res. Toxicol. 1998, 11, 273-283.
39. Scott, N., K. M. Hatlelid, MacKenzie, N. E. & D. E. Carter: Reactions of arsenic (III) species with glutathione. Chem. Res. Toxicol. 1993, 6, 102-106.
40. Styblo, M., H. Yamauchi & D. Thomas: Comparative in vitro methylation of trivalent and pentavalent arsenicals. Toxicol. Appl. Pharmacol. 1995, 135, 172-178.
41. Styblo, M., M. Delnomdedieu & D. J. Thomas: Mono-and dimethylation of arsenic in rat liver cytosol in vitro. Chem.-Biol. Interact. 1996, 99, 147-164.
42. Styblo, M. & D. J. Thomas: Binding of arsenicals to proteins in an in vitro methylation system. Toxicol. Appl. Pharmacol. 1997, 147, 1-8.
43. Styblo, M., S. V. Serves, W. R. Cullen & D. J. Thomas: Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 1997, 10, 27-33.
44. Styblo, M., L. M. Del Razo, E. L. LeCluyse, G. A. Hamilton, C. Wang, W. R. Cullen & D. J. Thomas: Metabolism of arsenic in primary cultures of human and rat hepatocytes. Chem. Res. Toxicol. 1999, 12, 560-565.
45. Styblo, M., L. M. Del Razo, L. Vega, D. R. Germolec, E. L. LeCluyse, G. A. Halminton, W. Reed, C. Wang, W. R. Cullen & D. J. Thomas: Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 2000, 74, 289-299.
46. Thompson, D. J.: A chemical hypothesis for arsenic methylation in mammals. Chem.-Biol. Interact. 1993, 88, 89-114.
47. Thornton, I. & M. Farago: The geochemistry of arsenic. In: Arsenic exposure and health effects II. Eds.: C. O. Abernathy, R. L. Calderon & W. R. Chappell. Chapman & Hall, New York, 1997, pp. 1-16.
48. Vahter, M. & E. Marafante: Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits. Chem.-Biol. Interact. 1983, 47, 29-44.
49. 74As dimethylarsinic acid in mice and rats. Arch. Environ. Contam. Toxicol. 1984, 13, 259-264.
50. Vahter, M. & E. Marafante: Reduction and binding of arsenate in marmoset monkeys. Arch. Toxicol. 1985, 57, 119-124.
51. Vahter, M. & E. Marafante: In vivo methylation and detoxication of arsenic. In: The biological alkylation of heavy elements. Eds.: P. J. Craig & F. Glockling. Royal Society of Chemistry, London, 1988, pp. 105-199.
52. Vahter, M.: Species differences in the metabolism of arsenic. In: Arsenic exposure and health. Eds.: W. R. Chappell, C. O. Abernathy & C. R. Cothern. Science and Technology Letters, Nothwood, 1994, pp. 171-179.
53. Vahter, M., R. Couch, B. Nermell & R. Nilsson: Lack of methylation of inorganic arsenic in the chimpanzee. Toxicol. Appl. Pharmacol. 1995a, 133, 262-268.
54. Vahter, M., G. Concha, B. Nermell, R. Nilsson, F. Dulout & A. T. Natarajan: A unique metabolism of inorganic arsenic in native Andean women. Eur. J. Pharmacol. 1995b, 293, 455-462.
55. Vahter, M.: Methylation of inorganic arsenic in different mammalian species and population groups. Sci. Prog. 1999a, 82, 69-88.
56. Vahter, M.: Variation in human metabolism of arsenic. In: Arsenic exposure and health effects. Eds.: W. R. Chappell, C. O. Abernathy & R. L. Calderon. Elsevier Science Ltd, Oxford, 1999b, pp. 267-279.
57. Vahter, M.: Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol. Lett. 2000, 112-113, 209-217.
58. Vahter, M., G. Concha & B. Nermell: Factors influencing arsenic methylation in humans. J. Trace Elem. Exp. Med. 2000, 13, 173-184.
59. Wanibuchi, H., S. Yamamoto, H. Chen, K. Yoshida, G. Endo, T. Hori & S. Fukushima: Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats. Carcinogenesis 1996, 17, 2435-2439.
60. Yamanaka, K., K. Ohtsubo, A. Hasegawa, I. H. Hayashi, H. Ohji, M. Kanisawa & S. Okada: Exposure to dimethylarsinic acid, a main metabolite of inorganic arsenics, strongly promotes tumorigenesis initiated by 4-nitroquinoline 1-oxide in the lungs of mice. Carcinogenesis 1996, 17, 767-770.
61. Yamauchi, H. & Y. Yamamura: Metabolism and excretion of orally administered dimethylarsinic acid in the hamster. Toxicol. Appl. Pharmacol. 1984, 74, 134-140.
62. Yang, C.-H., M.-L. Kuo, J.-C. Chen & Y.-C. Chen: Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells. Brit. J. Cancer 1999, 81, 796-799.
63. Yu, R. C., K. H. Hsu, C. J. Chen & J. R. Froines: Arsenic methylation capacity and skin cancer. Cancer Epidemiol. Biomarkers Prev. 2000, 9, 1259-1262.
64. Zakharyan, R. A., Y. Wu, G. M. Bogdan & H. V. Aposhian: Enzymatic methylation of arsenic compounds. I: Assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. Chem. Res. Toxicol. 1995, 8, 1029-1038.
65. Zakharyan, R. A., E. Wildfang & H. V. Aposhian: Enzymatic methylation of arsenic compounds: III. The marmoset and tamarin, but not the rhesus, monkey are deficient in methyltransferases that methylate inorganic arsenic. Toxicol. Appl. Pharmacol. 1996, 140, 77-84.
66. v reductase. Chem. Res. Toxicol. 1999a, 12, 1278-1283.
67. Zakharyan, R. A., F. Ayala-Fierro, W. R. Cullen, D. E. Carter & H. V. Aposhian: Enzymatic methylation of arsenic compounds: VII. Monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol. Appl. Pharmacol. 1999b, 158, 9-15.